Feasibility and utility of a combined nasogastric-tube-and-string-test device for bacteriologic confirmation of pulmonary tuberculosis in young children.

Diagnosis Gastric aspirate Microbiological confirmation Pediatric tuberculosis String

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
18 Apr 2024
Historique:
received: 22 12 2023
revised: 03 04 2024
accepted: 10 04 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: aheadofprint

Résumé

For microbiological confirmation of pediatric pulmonary tuberculosis (PTB), gastric aspirates (GA) are often operationally unfeasible without hospitalization, and the encapsulated orogastric string test is not easily swallowed in young children. The Combined-NasoGastric-Tube-and-String-Test (CNGTST) enables dual collection of GA and string specimens. In a prospective cohort study in Kenya, we examined its feasibility in children under five with presumptive PTB and compared the bacteriological yield of string to GA. Paired GA and string samples were successfully collected in 95.6 % (281/294) of children. Mycobacterium tuberculosis was isolated from 7.0 % (38/541) of GA and 4.3 % (23/541) of string samples, diagnosing 8.2 % (23/281) of children using GA and 5.3 % (15/281) using string. The CNGTST was feasible in nearly all children. Yield from string was two-thirds that of GA despite a half-hour median dwelling time. In settings where the feasibility of hospitalisation for GA is uncertain, the string component can be used to confirm PTB.

Identifiants

pubmed: 38657352
pii: S0732-8893(24)00131-7
doi: 10.1016/j.diagmicrobio.2024.116302
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116302

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Nisreen Khambati (N)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: nisreen.khambati@stcatz.ox.ac.uk.

Rinn Song (R)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA USA; Department of Pediatrics, Harvard Medical School, Boston, MA USS.

Jonathan P Smith (JP)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States.

Else Margreet Bijker (EM)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Department of Pediatrics, Maastricht University Medical Center, MosaKids Children's Hospital, Maastricht, the Netherlands.

Kimberly McCarthy (K)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.

Eleanor S Click (ES)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.

Walter Mchembere (W)

Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya.

Albert Okumu (A)

Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya.

Susan Musau (S)

Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya.

Elisha Okeyo (E)

Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya.

Carlos M Perez-Velez (CM)

University of Arizona College of Medicine, Tucson, AZ USA.

Kevin Cain (K)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.

Classifications MeSH